PHD1/prolyl hydroxylase antibody | knockout validation | Abcam ab113077

This is a knockout-validated antibody summary, based on the publications "Prolyl hydroxylase domain proteins regulate bone mass through their expression in osteoblasts", as cited below [1], and "Control of endothelial quiescence by FOXO-regulated metabolites" for western blot knockout validation (figure s10a) [2]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: PHD1/prolyl hydroxylase

Catalog number: ab113077

Summary: Rabbit monoclonal IgG against a synthetic peptide corresponding to residues in human PHD1/prolyl hydroxylase. Reacts with mouse, rat, and human. Suitable for western blot, immunocytochemistry, immunohistochemistry (paraffin) and immunoprecipitation. Unsuitable for flow cytometry.

Validation Method

Immunohistochemistry

Sample

WT and Phd1–3ob−/− mouse tibiae. Tissues were fixed in 10% formalin, decalcified and embedded in paraffin.

Secondary incubation

EnVision System HRP (Dako North America, Inc., Carpinteria, CA).

Figure

Immunohistochemical staining of femoral sections of 2-month-old control and Phd1–3ob−/− male mice with antibodies against PHD1, PHD2, PHD3 or normal IgG. Arrows indicate PHD-expressing osteoblasts located on trabecular surfaces. Please see Figure 1 in the article [1].

References
  1. Zhu K, Song P, Lai Y, Liu C, Xiao G. Prolyl hydroxylase domain proteins regulate bone mass through their expression in osteoblasts. Gene. 2016;594:125-130 pubmed publisher
  2. Andrade J, Shi C, Costa A, Choi J, Kim J, Doddaballapur A, et al. Control of endothelial quiescence by FOXO-regulated metabolites. Nat Cell Biol. 2021;23:413-423 pubmed publisher